Iovance Biotherapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell IOVA and other ETFs, options, and stocks.About IOVA
Iovance Biotherapeutics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of cell therapies as novel cancer immunotherapy products. Its lead product candidate, LN-144 for metastatic melanoma, is an autologous adoptive cell therapy utilizing tumor-infiltrating lymphocytes (TIL), which are T cells derived from patients' tumors.
IOVA Key Statistics
Stock Snapshot
As of today, Iovance Biotherapeutics(IOVA) shares are valued at $2.60. The company's market cap stands at 1.06B, with a P/E ratio of -2.16.
During the trading session on 2026-02-10, Iovance Biotherapeutics(IOVA) shares reached a daily high of $2.73 and a low of $2.57. At a current price of $2.60, the stock is +1.2% higher than the low and still -4.6% under the high.
Trading activity shows a volume of 8.5M, compared to an average daily volume of 10.26M.
The stock's 52-week range extends from a low of $1.64 to a high of $6.09.
The stock's 52-week range extends from a low of $1.64 to a high of $6.09.
IOVA News
Advertisement What triggered the latest focus on Iovance Biotherapeutics (IOVA)? The spotlight on Iovance Biotherapeutics (IOVA) stems from its shift into a c...
Analyst ratings
58%
of 12 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.